Day: April 21, 2022

Studies Hit Roll-Out Opinion on Cannabinoid Formulations for Parkinson’s

Investigators are taking the first steps towards human trials on a novel formulation of cannabinoids designed to target Parkinson’s disease. Gb Sciences, a US-based research and development company, has announced it will begin dosage studies to test its patent-protected cannabinoid-based formulations, in an animal model of Parkinson’s next month. These studies will determine the dose range …

Studies Hit Roll-Out Opinion on Cannabinoid Formulations for Parkinson’s Read More »

Insight on Why 420 Cannabis Fest is a Ray of Hope for Health Care Equality

By now, we have all become accustomed to the celebratory spirit among cannabis enthusiasts that accompanies April 20, particularly in regulated markets. Once known only to a counterculture crowd, the annual “weed holiday” is becoming more and more mainstream. Even those who have never visited a marijuana store have heard talk of “4/20.” Brands increasingly …

Insight on Why 420 Cannabis Fest is a Ray of Hope for Health Care Equality Read More »